Inventor
CRAIG L. DUVALL
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes27%
C07KPeptides18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds9%
Y02ATechnologies for adaptation to climate change9%
PatentTitleYear
12,201,644Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing202511,707,483Micellic assemblies202311,147,827Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNIV VANDERBILT (2)· patent assignee history
2021–2025Based in US· patent location history
2023Patents assigned to GENEVANT SCIENCES GMBH (1)· patent assignee history
2023Patents assigned to UNIV WASHINGTON (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV VANDERBILT | 2 | 2021–2025 |
| GENEVANT SCIENCES GMBH | 1 | 2023 |
| UNIV WASHINGTON | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2021–2025 |